The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: A case-control study in the Portuguese population

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 593-598

  Silva, Susana N ^a   Azevedo, Ana Paula ^b   Teixeira, Valdemar ^b   Pina, Julieta Esperança ^a   Rueff, José ^a   Gaspar, Jorge Francisco ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

Author keywords

Breast cancer; Genetic susceptibility; GSTA2 polymorphisms

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE 2; UNCLASSIFIED DRUG; GLUTATHIONE S-TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE ALPHA; ISOENZYME;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNICITY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; PORTUGAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; CASE CONTROL STUDY; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; ISOENZYMES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL;

EID: 70349305590     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000477     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Bradbury AR and Olopade OI: Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 8: 255-267, 2007.
3. Dapic V, Carvalho MA and Monteiro AN: Breast cancer susceptibility and the DNA damage response. Cancer Control 12: 127-136, 2005.
4. Silva SN, Cabral MN, Bezerra de CG, Pires M, Azevedo AP, Manita I, Pina JE, Rueff J and Gaspar J: Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17beta1, COMT and MnSOD): possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed. Oncol Rep 16: 781-788, 2006.
5. Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE and Shen CY: Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113: 345-353, 2005.
6. Torresan C, Oliveira MM, Torrezan GT, de Oliveira SF, Abuazar CS, Losi-Guembarovski R, Lima RS, Urban CA, Cavalli IJ and Ribeiro EM: Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin Exp Med 8: 65-71, 2008.
7. Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr pp67-73, 2000.
8. Crooke PS, Ritchie MD, Hachey DL, Dawling S, Roodi N and Parl FF: Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol Biomarkers Prev 15: 1620-1629, 2006.
9. McIlwain CC, Townsend DM and Tew KD: Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648, 2006.
10. Unlu A, Ates NA, Tamer L and Ates C: Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk. Cell Biochem Funct 26: 643-647, 2008.
11. Hayes JD, Flanagan JU and Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88, 2005.
12. Tetlow N and Board PG: Functional polymorphism of human glutathione transferase A2. Pharmacogenetics 14: 111-116, 2004.
13. Tetlow N, Liu D and Board P: Polymorphism of human alpha class glutathione transferases. Pharmacogenetics 11: 609-617, 2001.
14. Coles BF and Kadlubar FF: Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401: 9-42, 2005.
15. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C and Ambrosone CB: Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27: 1876-1882, 2006.
16. Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gaborieau V, Gioia-Patricola L, Bellini I, Barale R, Canzian F, Hall J, Boffetta P, Hung RJ and Brennan P: Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28: 1287-1293, 2007.
17. Ning B, Wang C, Morel F, Nowell S, Ratnasinghe DL, Carter W, Kadlubar FF and Coles B: Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics 14: 35-44, 2004.
18. Tetlow N, Coggan M, Casarotto MG and Board PG: Functional polymorphism of human glutathione transferase A3: effects on xenobiotic metabolism and steroid biosynthesis. Pharmacogenetics 14: 657-663, 2004.
19. Steck SE, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Santella RM and Gammon MD: Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 28: 1954-1959, 2007.
20. Saxena A, Dhillon VS, Raish M, Asim M, Rehman S, Shukla NK, Deo SV, Ara A and Husain SA: Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res Treat (In press).
21. Lee SA, Fowke JH, Lu W, Ye C, Zheng Y, Cai Q, Gu K, Gao YT, Shu XO and Zheng W: Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 87: 753-760, 2008.
22. Syamala VS, Sreeja L, Syamala V, Raveendran PB, Balakrishnan R, Kuttan R and Ankathil R: Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer 7: 213-220, 2008.
23. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P and Boffetta P: Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13: 1473-1479, 2004.
24. Zheng T, Holford TR, Zahm SH, Owens PH, Boyle P, Zhang Y, Zhang B, Wise JP Sr, Stephenson LP and li-Osman F: Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk. Br J Cancer 88: 58-62, 2003.
25. Zheng W, Wen WQ, Gustafson DR, Gross M, Cerhan JR and Folsom AR: GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat 74: 9-16, 2002.
26. Maugard CM, Charrier J and Bignon YJ: Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. Chem Biol Interact 111-112: 365-375, 1998.
27. Lange K, Cantor R, Horvath S, Perola M, Sabatti C, Sinsheimer J and Sobel E: Mendel version 4.0: A complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 69 (Suppl): A1886, 2001.
28. Sole X, Guino E, Valls J, Iniesta R and Moreno V: SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929, 2006.
29. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capella G and Canzian F: A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15: 535-546, 2005.
30. Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, Canessa PA, Canzian F, Ceppi M, Filiberti R, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Mutti L and Puntoni R: Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 120: 2739-2743, 2007.
31. Coles BF, Anderson KE, Doerge DR, Churchwell MI, Lang NP and Kadlubar FF: Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res 60: 573-579, 2000.
32. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP and Kadlubar FF: Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11: 663-669, 2001.
33. Kelley MK, Engqvist-Goldstein A, Montali JA, Wheatley JB, Schmidt DE Jr and Kauvar LM: Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochem J 304: 843-848, 1994.
34. Guy CA, Hoogendoorn B, Smith SK, Coleman S, O'Donovan MC and Buckland PR: Promoter polymorphisms in glutathione-S-transferase genes affect transcription. Pharmacogenetics 14: 45-51, 2004.
35. Morel F, Rauch C, Coles B, Le FE and Guillouzo A: The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 12: 277-286, 2002.
36. Dialyna IA, Arvanitis DA and Spandidos DA: Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. Int J Mol Med 8: 79-87, 2001.